BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6930663)

  • 21. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
    Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
    Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteases act synergistically with low molecular weight inducers to stimulate mouse erythroleukemia cell differentiation.
    Scher W; Scher BM; Waxman S
    Exp Hematol; 1983 Jul; 11(6):490-8. PubMed ID: 6352299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cellular transition from G1-resting to G1-prereplicative phase by aminonucleoside of puromycin.
    Cholon JJ; Knopf RG; Pine RM
    In Vitro; 1979 Sep; 15(9):736-42. PubMed ID: 231571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of differentiation in murine erythroleukemia cells by 1 alpha,25-dihydroxy vitamin D3.
    Radhika S; Choudhary SK; Garg LC; Dixit A
    Cancer Lett; 1995 Apr; 90(2):225-30. PubMed ID: 7736459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducers of erythroid differentiation in K562 human leukemia cells.
    Rowley PT; Ohlsson-Wilhelm BM; Farley BA; LaBella S
    Exp Hematol; 1981 Jan; 9(1):32-7. PubMed ID: 6940756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylated oxypurines and induction of differentiation of murine erythroleukemia cells.
    Kerr SJ
    Mol Cell Biochem; 1990 Jan; 92(1):37-44. PubMed ID: 2106620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z; Banks J; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procaine inhibits the erythroid differentiation of MEL cells by blocking commitment: possible involvement of calcium metabolism.
    Tsiftsoglou AS; Mitrani AA; Housman DE
    J Cell Physiol; 1981 Sep; 108(3):327-35. PubMed ID: 6793604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
    Fibach E; Gambari R; Shaw PA; Maniatis G; Reuben RC; Sassa S; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1906-10. PubMed ID: 287029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation and malignant suppression induced by mouse erythroid differentiation and denucleation factor on mouse erythroleukemia cells.
    Daishu H; Qing Z; Yehua G; Jianping Z; Jing M; Kequan C; Shepu X
    Chin Med Sci J; 2002 Dec; 17(4):199-203. PubMed ID: 12901505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New designed HMBA agents as inducers of erythroleukemia cell differentiation.
    Wang H; Zhang S; Zhou J; Zhang J
    Chin Med Sci J; 2002 Mar; 17(1):27-31. PubMed ID: 12894881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth and differentiation of Friend erythroleukemia cells in serum-free culture.
    Jemma C; Rossi GB
    Leuk Res; 1983; 7(5):591-7. PubMed ID: 6580516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perturbation of growth and differentiation of Friend murine erythroleukemia cells by 5-bromodeoxyuridine incorporation in early S phase.
    Brown EH; Schildkraut CL
    J Cell Physiol; 1979 May; 99(2):261-78. PubMed ID: 287673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line.
    Matsuzaki T; Aisaki Ki; Yamamura Y; Noda M; Ikawa Y
    Oncogene; 2000 Mar; 19(12):1500-8. PubMed ID: 10734309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells in the absence of cytokinesis.
    Tsiftsoglou AS; Sartorelli AC
    Cancer Res; 1979 Oct; 39(10):4058-63. PubMed ID: 289437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of proliferation and differentiation of mouse erythroleukemia cells by hydroxamic acids.
    Anders CU; von Kreybig T; Koch G
    Leuk Res; 1985; 9(4):463-9. PubMed ID: 3858612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lengthening of the G1 phase is not strictly correlated with differentiation in Friend erythroleukemia cells.
    Friedman EA; Schildkraut CL
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3813-7. PubMed ID: 278993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nascent RNA chain termination and ultrastructural changes in nucleoli isolated from SV40-transformed fibroblasts treated with aminonucleoside of puromycin.
    Studzinski GP; Albanese EA
    Lab Invest; 1980 Nov; 43(5):427-33. PubMed ID: 6158625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered expression of beta-globin, transferrin receptor, and ornithine decarboxylase in Friend murine erythroleukemia cells inhibited by alpha-difluoromethylornithine.
    Klinken SP; Billelo J; Bauer S; Morse HC; Thorgeirsson SS
    Cancer Res; 1987 May; 47(10):2638-44. PubMed ID: 2436752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.